Kunyong Xu, MD

44% fewer Medicare Part D claims than the average retina specialist (ophthalmology) physician in 2024

348 Medicare Part D claims for 183 beneficiaries, against an average of 620 among the 1,449 providers of this specialty who prescribed in Part D. Brand-name drugs were 20% of claims. 15 claims were for opioids.

Most prescribed

1. Erythromycin56 claims
2. Prednisolone Acetate52 claims
3. Moxifloxacin47 claims
4. Ofloxacin28 claims
5. Ketorolac Tromethamine26 claims
6. Timolol Maleate23 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

The practice group's MIPS final score for 2023 (Medicare payment program): 100 of 100

The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.

Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).

Industry payments in 2024: $2,181.30

30 payments; by number, the most common kind was food and beverage; the largest payer was Alimera Sciences, Inc. The 1,253 providers of this specialty with any payment received $7,667.49 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.

Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.

Bills Medicare through 2 group practices

1. Associated Retina Consultants LtdPhoenix, AZ
2. District Medical Group IncPhoenix, AZ

Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).